Operating Expenses Endring Dato
Acadia Pharmaceuticals USD 196.1M 73.38M 2023-12
Agios Pharmaceuticals USD 113.38M 5.08M 2023-12
Alnylam Pharmaceuticals USD 556.12M 19.46M 2023-12
Amarin USD 87.51M 16.62M 2023-09
Amgen USD 6.93B 2.11B 2023-12
Baxter International USD 3.59B 173M 2023-12
Cara Therapeutics USD 33.76M 5.51M 2023-09
Cytokinetics USD 129.09M 6.45M 2023-12
Eli Lilly USD 6.97B 2.08B 2023-12
Esperion Therapeutics USD 61.5M 1.34M 2023-09
Halozyme Therapeutics USD 129M 1.25M 2023-12
Intra Cellular Therapies USD 166.2M 10.31M 2023-12
Intrexon USD 22.32M 571K 2023-09
Ionis Pharmaceuticals USD 303.83M 14.26M 2023-12
MannKind USD 50.61M 4.46M 2023-12
Minerva Neurosciences USD 6.08M 1.56M 2023-09
Nektar Therapeutics USD 69.01M 2.09M 2023-09
Peregrine Pharmaceuticals USD 36.62M 3.27M 2023-09
Pfizer USD 20.8B 4.62B 2023-12
Rigel Pharmaceuticals USD 32.6M 446K 2023-09
United Therapeutics USD 354.6M 72.2M 2023-12
Vanda Pharmaceuticals USD 48.92M 11.57M 2023-06



Halozyme Therapeutics Driftskostnader - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2024.